Export

ATC codes: L01DC01
EMLc
Indication
Other specified malignant neoplasms of the ovary ICD11 code: 2D23.Y
INN
Bleomycin
Medicine type
Chemical agent
List type
Complementary
Formulations
Parenteral > General injections > unspecified: 15 mg in vial (as sulfate)
EML status history
First added in 1979 (TRS 641)
Changed in 2015 (TRS 994)
Sex
All
Age
Also recommended for children
Therapeutic equivalence
The recommendation is for this specific medicine
Patent information
Patents have expired in most jurisdictions
Tags
Wikipedia
DrugBank
Summary of evidence and Expert Committee recommendations
In 2015, as part of the comprehensive review of cancer medicines undertaken by the Expert Committee, listing for bleomycin on the complementary list of the EML and EMLc for use in treatment protocols for ovarian germ cell tumours was specifically endorsed. The relevant extract from TRS994 regarding the Expert Committee's 2015 consideration of treatment protocols for ovarian germ cell tumours is attached.